Half a century of amyloids: past, present and future

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Standard

Half a century of amyloids : past, present and future. / Ke, Pu Chun; Zhou, Ruhong; Serpell, Louise C; Riek, Roland; Knowles, Tuomas P J; Lashuel, Hilal A; Gazit, Ehud; Hamley, Ian W; Davis, Thomas P; Fändrich, Marcus; Otzen, Daniel Erik; Chapman, Matthew R; Dobson, Christopher M; Eisenberg, David S; Mezzenga, Raffaele.

In: Chemical Society Reviews, Vol. 49, No. 15, 07.08.2020, p. 5473-5509.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Harvard

Ke, PC, Zhou, R, Serpell, LC, Riek, R, Knowles, TPJ, Lashuel, HA, Gazit, E, Hamley, IW, Davis, TP, Fändrich, M, Otzen, DE, Chapman, MR, Dobson, CM, Eisenberg, DS & Mezzenga, R 2020, 'Half a century of amyloids: past, present and future', Chemical Society Reviews, vol. 49, no. 15, pp. 5473-5509. https://doi.org/10.1039/c9cs00199a

APA

Ke, P. C., Zhou, R., Serpell, L. C., Riek, R., Knowles, T. P. J., Lashuel, H. A., Gazit, E., Hamley, I. W., Davis, T. P., Fändrich, M., Otzen, D. E., Chapman, M. R., Dobson, C. M., Eisenberg, D. S., & Mezzenga, R. (2020). Half a century of amyloids: past, present and future. Chemical Society Reviews, 49(15), 5473-5509. https://doi.org/10.1039/c9cs00199a

CBE

Ke PC, Zhou R, Serpell LC, Riek R, Knowles TPJ, Lashuel HA, Gazit E, Hamley IW, Davis TP, Fändrich M, Otzen DE, Chapman MR, Dobson CM, Eisenberg DS, Mezzenga R. 2020. Half a century of amyloids: past, present and future. Chemical Society Reviews. 49(15):5473-5509. https://doi.org/10.1039/c9cs00199a

MLA

Ke, Pu Chun et al. "Half a century of amyloids: past, present and future". Chemical Society Reviews. 2020, 49(15). 5473-5509. https://doi.org/10.1039/c9cs00199a

Vancouver

Ke PC, Zhou R, Serpell LC, Riek R, Knowles TPJ, Lashuel HA et al. Half a century of amyloids: past, present and future. Chemical Society Reviews. 2020 Aug 7;49(15):5473-5509. https://doi.org/10.1039/c9cs00199a

Author

Ke, Pu Chun ; Zhou, Ruhong ; Serpell, Louise C ; Riek, Roland ; Knowles, Tuomas P J ; Lashuel, Hilal A ; Gazit, Ehud ; Hamley, Ian W ; Davis, Thomas P ; Fändrich, Marcus ; Otzen, Daniel Erik ; Chapman, Matthew R ; Dobson, Christopher M ; Eisenberg, David S ; Mezzenga, Raffaele. / Half a century of amyloids : past, present and future. In: Chemical Society Reviews. 2020 ; Vol. 49, No. 15. pp. 5473-5509.

Bibtex

@article{5a382e2248be4fafb9c9f6f0cf59c65f,
title = "Half a century of amyloids: past, present and future",
abstract = "Amyloid diseases are global epidemics with profound health, social and economic implications and yet remain without a cure. This dire situation calls for research into the origin and pathological manifestations of amyloidosis to stimulate continued development of new therapeutics. In basic science and engineering, the cross-β architecture has been a constant thread underlying the structural characteristics of pathological and functional amyloids, and realizing that amyloid structures can be both pathological and functional in nature has fuelled innovations in artificial amyloids, whose use today ranges from water purification to 3D printing. At the conclusion of a half century since Eanes and Glenner's seminal study of amyloids in humans, this review commemorates the occasion by documenting the major milestones in amyloid research to date, from the perspectives of structural biology, biophysics, medicine, microbiology, engineering and nanotechnology. We also discuss new challenges and opportunities to drive this interdisciplinary field moving forward.",
author = "Ke, {Pu Chun} and Ruhong Zhou and Serpell, {Louise C} and Roland Riek and Knowles, {Tuomas P J} and Lashuel, {Hilal A} and Ehud Gazit and Hamley, {Ian W} and Davis, {Thomas P} and Marcus F{\"a}ndrich and Otzen, {Daniel Erik} and Chapman, {Matthew R} and Dobson, {Christopher M} and Eisenberg, {David S} and Raffaele Mezzenga",
year = "2020",
month = aug,
day = "7",
doi = "10.1039/c9cs00199a",
language = "English",
volume = "49",
pages = "5473--5509",
journal = "Chemical Society Reviews",
issn = "0306-0012",
publisher = "Royal Society of Chemistry",
number = "15",

}

RIS

TY - JOUR

T1 - Half a century of amyloids

T2 - past, present and future

AU - Ke, Pu Chun

AU - Zhou, Ruhong

AU - Serpell, Louise C

AU - Riek, Roland

AU - Knowles, Tuomas P J

AU - Lashuel, Hilal A

AU - Gazit, Ehud

AU - Hamley, Ian W

AU - Davis, Thomas P

AU - Fändrich, Marcus

AU - Otzen, Daniel Erik

AU - Chapman, Matthew R

AU - Dobson, Christopher M

AU - Eisenberg, David S

AU - Mezzenga, Raffaele

PY - 2020/8/7

Y1 - 2020/8/7

N2 - Amyloid diseases are global epidemics with profound health, social and economic implications and yet remain without a cure. This dire situation calls for research into the origin and pathological manifestations of amyloidosis to stimulate continued development of new therapeutics. In basic science and engineering, the cross-β architecture has been a constant thread underlying the structural characteristics of pathological and functional amyloids, and realizing that amyloid structures can be both pathological and functional in nature has fuelled innovations in artificial amyloids, whose use today ranges from water purification to 3D printing. At the conclusion of a half century since Eanes and Glenner's seminal study of amyloids in humans, this review commemorates the occasion by documenting the major milestones in amyloid research to date, from the perspectives of structural biology, biophysics, medicine, microbiology, engineering and nanotechnology. We also discuss new challenges and opportunities to drive this interdisciplinary field moving forward.

AB - Amyloid diseases are global epidemics with profound health, social and economic implications and yet remain without a cure. This dire situation calls for research into the origin and pathological manifestations of amyloidosis to stimulate continued development of new therapeutics. In basic science and engineering, the cross-β architecture has been a constant thread underlying the structural characteristics of pathological and functional amyloids, and realizing that amyloid structures can be both pathological and functional in nature has fuelled innovations in artificial amyloids, whose use today ranges from water purification to 3D printing. At the conclusion of a half century since Eanes and Glenner's seminal study of amyloids in humans, this review commemorates the occasion by documenting the major milestones in amyloid research to date, from the perspectives of structural biology, biophysics, medicine, microbiology, engineering and nanotechnology. We also discuss new challenges and opportunities to drive this interdisciplinary field moving forward.

U2 - 10.1039/c9cs00199a

DO - 10.1039/c9cs00199a

M3 - Review

C2 - 32632432

VL - 49

SP - 5473

EP - 5509

JO - Chemical Society Reviews

JF - Chemical Society Reviews

SN - 0306-0012

IS - 15

ER -